CL2020001392A1 - Composiciones para uso en la reducción de la nocicepción en infantes y niños pequeños. - Google Patents

Composiciones para uso en la reducción de la nocicepción en infantes y niños pequeños.

Info

Publication number
CL2020001392A1
CL2020001392A1 CL2020001392A CL2020001392A CL2020001392A1 CL 2020001392 A1 CL2020001392 A1 CL 2020001392A1 CL 2020001392 A CL2020001392 A CL 2020001392A CL 2020001392 A CL2020001392 A CL 2020001392A CL 2020001392 A1 CL2020001392 A1 CL 2020001392A1
Authority
CL
Chile
Prior art keywords
compositions
infants
nociception
young children
reduction
Prior art date
Application number
CL2020001392A
Other languages
English (en)
Inventor
Norbert Sprenger
Sami Damak
Francis Foata
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of CL2020001392A1 publication Critical patent/CL2020001392A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Pediatric Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dairy Products (AREA)

Abstract

La presente invención describe composiciones que comprenden 6’-sialilactosa (6’SL) y lacto-N-tetraosa (LNT), para uso en la reducción de la nocicepción en un infante o en un niño pequeño. Las composiciones son, en particular, útiles para reducir el dolor abdominal y, consecuentemente también contribuyen a reducir los períodos de llanto y a mejorar la calidad del sueño y la calidad de vida general de los infantes y niños pequeños.
CL2020001392A 2017-12-22 2020-05-27 Composiciones para uso en la reducción de la nocicepción en infantes y niños pequeños. CL2020001392A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17209905 2017-12-22

Publications (1)

Publication Number Publication Date
CL2020001392A1 true CL2020001392A1 (es) 2020-10-02

Family

ID=60888219

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2020001392A CL2020001392A1 (es) 2017-12-22 2020-05-27 Composiciones para uso en la reducción de la nocicepción en infantes y niños pequeños.

Country Status (8)

Country Link
US (2) US11357785B2 (es)
EP (1) EP3727038B1 (es)
CN (2) CN118452467A (es)
AU (1) AU2018390181A1 (es)
CL (1) CL2020001392A1 (es)
MX (1) MX2020007197A (es)
PH (1) PH12020550959A1 (es)
WO (1) WO2019121929A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2924137T3 (es) * 2016-05-05 2022-10-04 Glycom As Composición que comprende HMOS para uso en el tratamiento de la hipersensibilidad y/o dolor visceral mediados por mastocitos
CN113194960A (zh) 2018-12-19 2021-07-30 格礼卡姆股份公司 用于治疗使用低fodmap饮食的人的组合物和方法
MX2021006189A (es) 2018-12-21 2021-06-23 Nestle Sa Una composicion nutricional que comprende 2'-fucasillactosa (2'fl) para mejorar la barrera gastrointestinal.
EP3897663A4 (en) * 2018-12-21 2022-09-07 Glycom A/S COMPOSITION AND METHOD FOR PROMOTING HEALING OF THE INTESTINAL BARRIER
CN113163833A (zh) * 2018-12-21 2021-07-23 雀巢产品有限公司 包含6′sl和lnt的组合以改善胃肠屏障功能的营养组合物
EP3952882A4 (en) * 2019-04-09 2023-01-18 Intrinsic Medicine, Inc. IMMUNO-MODULATORY OLIGOSACCHARIDES FOR PAIN TREATMENT
WO2020250185A1 (en) * 2019-06-12 2020-12-17 Glycom A/S Human milk oligosaccharides and compositions thereof for use in preventing, managing or treating symptoms related to migraine
US12533368B2 (en) 2019-12-06 2026-01-27 Societe Des Produits Nestle S.A. Compositions for use in the reduction of pain and/or perception of pain in infants and young children
AU2020399200A1 (en) * 2019-12-11 2022-06-09 Société des Produits Nestlé S.A. Compositions for use in the reduction of nociception and other health benefits in infants and young children
CA3178744C (en) 2020-05-13 2023-11-14 Ardythe L. Morrow Fucosylated oligosaccharides for prevention of coronavirus infection
WO2021231750A1 (en) * 2020-05-13 2021-11-18 Glycosyn LLC 2'-fucosyllactose for the prevention and treatment of coronavirus-induced inflammation
CN116391026A (zh) * 2020-06-26 2023-07-04 雀巢产品有限公司 产生丝氨酸蛋白酶抑制剂
WO2022117538A1 (en) * 2020-12-01 2022-06-09 Frieslandcampina Nederland B.V. 2'-fucosyllactose for use in stimulating f. prausnitzii abundance
CN116490079A (zh) * 2020-12-04 2023-07-25 雀巢产品有限公司 用于在个体中使用以支持夜间睡眠持续时间的包含人乳低聚糖的组合物
EP4255444A4 (en) * 2020-12-04 2024-10-16 Glycom A/S Human milk oligosaccharides for use in supporting maturation or improvement of sleeping patterns
WO2022118270A1 (en) * 2020-12-04 2022-06-09 Glycom A/S Human milk oligosaccharides for use in supporting night sleep duration
EP4313064A1 (en) * 2021-03-22 2024-02-07 Société des Produits Nestlé S.A. Human milk oligosaccharides
EP4712795A2 (en) * 2023-05-16 2026-03-25 Société des Produits Nestlé S.A. Nutritional composition and method for promoting sleep and/or for treating and/or preventing sleep disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991016449A1 (en) 1990-04-16 1991-10-31 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
US5545553A (en) 1994-09-26 1996-08-13 The Rockefeller University Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
RU2433751C2 (ru) 2009-05-05 2011-11-20 Александр Владимирович Диковский Композиция для нормализации микрофлоры и очищения организма от токсинов и способ оздоровления организма
EP2454948A1 (en) * 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
CN105722409A (zh) * 2013-11-15 2016-06-29 雀巢产品技术援助有限公司 用于预防或治疗婴儿和幼儿的坏死性小肠结肠炎的组合物
US20160243139A1 (en) 2014-10-29 2016-08-25 Glycom A/S Composition comprising HMSs/HMOs and use thereof
EP3212197A4 (en) * 2014-10-29 2018-07-11 Glycom A/S Synthetic composition and method for treating irritable bowel syndrome
CN107404925A (zh) 2015-03-05 2017-11-28 雀巢产品技术援助有限公司 用于预防或治疗婴儿或幼儿胃肠感染/炎症的组合物
CN107846957A (zh) 2015-03-05 2018-03-27 雀巢产品技术援助有限公司 用于改善婴儿或幼儿粪便稠度或频率的组合物
EP3389668A4 (en) 2015-12-15 2019-08-21 Glycom A/S MIXTURE OF HMOS

Also Published As

Publication number Publication date
US20220331347A1 (en) 2022-10-20
CN118452467A (zh) 2024-08-09
EP3727038A1 (en) 2020-10-28
US20200330493A1 (en) 2020-10-22
RU2020123416A3 (es) 2022-04-08
US11357785B2 (en) 2022-06-14
RU2020123416A (ru) 2022-01-18
US12109220B2 (en) 2024-10-08
PH12020550959A1 (en) 2021-04-26
CN111432661A (zh) 2020-07-17
MX2020007197A (es) 2020-09-03
BR112020010958A2 (pt) 2020-11-17
AU2018390181A1 (en) 2020-05-28
WO2019121929A1 (en) 2019-06-27
EP3727038B1 (en) 2026-02-25

Similar Documents

Publication Publication Date Title
CL2020001392A1 (es) Composiciones para uso en la reducción de la nocicepción en infantes y niños pequeños.
CL2018001825A1 (es) Composiciones que comprenden 2fl y lnnt para usar en infantes o niños pequeños para prevenir la obesidad en la vida posterior o comorbilidades relacionadas
CR20220082A (es) N4-hidroxicitidina y derivados y usos antivirales relacionados con los mismos
MX2017010923A (es) Composiciones para usar en el mejoramiento de la consistencia o la frecuencia de las heces en infantes o niños pequeños.
MX377225B (es) Mezcla sintetica de oligosacaridos de la leche humana (hmo) y composición que la contiene.
PH12019550208A1 (en) Hmos blends for use in infants or young children for health purposes
CL2020001195A1 (es) Composiciones que comprenden al menos un oligosacárido n-acetilado y al menos uno fucosilado para usar en la promoción de la capacidad digestiva en infantes y niños pequeños.
CL2019000132A1 (es) Composición lipídica para usar en infantes y niños pequeños para promover el confort del intestino y la óptima absorción de grasa y calcio.
MX2017010922A (es) Composiciones para usar en la prevencion o el tratamiento de infecciones/inflamaciones gastrointestinales en infantes o niños pequeños.
MX2022011064A (es) Metodos para disminuir la incidencia de la enterocolitis necrotizante en bebes, infantes, o ni?os al usar los oligosacaridos de leche humana.
CL2018001826A1 (es) Composiciones que comprenden 2fl y lnnt para controlar la ingesta de alimento y el crecimiento en infantes o niños pequeños
MX2017010924A (es) Composiciones para uso en la prevencion o el tratamiento de otitis o bronquitis en infantes o niños pequeños.
GB202214665D0 (en) Child's chair or highchair
MX2016006574A (es) Composiciones nutritivas adaptadas a la edad con un contenido de proteina variable.
BR112013000497A2 (pt) arranjo de fómulas nutricionais projetadas de acordo com a idade com teor ótimo de gordura
BR112017004294A2 (pt) composição nutricional com baixo teor de ácidos graxos de cadeia média em proporções específicas e seus usos
CL2016001449A1 (es) Un sistema de nutrición adaptado a la edad para un infante
BR112018010443A2 (pt) composições nutricionais e fórmulas para bebês para promover mielinização no cérebro
CL2022001255A1 (es) Composiciones para usar en la reducción de dolor y o percepción de dolor
BR112018010278A2 (pt) composições nutricionais e fórmulas para bebês para promover mielinização no cérebro
CL2018001595A1 (es) Composiciones nutricionales y fórmulas infantiles para promover la mielinización en el cerebro
BR112018067926A2 (pt) composições nutricionais e seus usos
BR112017007362A2 (pt) composições nutricionais compreendendo sn-1(3)-monoacilgliceróis para uso no tratamento de atrasos de crescimento em bebês ou crianças
Morozova et al. Psychological aspects in the education of children in substitute families
TH2001005750A (th) องค์ประกอบทางโภชนาการสำหรับใช้ในการป้องกันผิวแห้ง